HealthEquity Stock Forecast

Stock Price Forecast

The 14 analysts with 12-month price forecasts for HealthEquity stock have an average target of 115.93, with a low estimate of 89 and a high estimate of 129. The average target predicts an increase of 47.95% from the current stock price of 78.36.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$89	$115.93	$120	$129
Change	+13.58%	+47.95%	+53.14%	+64.62%

Analyst Ratings

The average analyst rating for HealthEquity stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	5	5	4	4	4	4
Buy	9	8	9	9	9	8
Hold	1	2	2	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	1	1	1
Total	15	15	15	15	15	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Glen Santangelo Barclays	Barclays	Buy Maintains $118 → $110	Buy	Maintains	$118 → $110	+40.38%	Feb 18, 2026
David Larsen BTIG	BTIG	Strong Buy Maintains $130 → $110	Strong Buy	Maintains	$130 → $110	+40.38%	Feb 17, 2026
David Roman Goldman Sachs	Goldman Sachs	Hold → Strong Sell Downgrades $89	Hold → Strong Sell	Downgrades	$89	+13.58%	Jan 9, 2026
Scott Schoenhaus Keybanc	Keybanc	Buy Maintains $120 → $125	Buy	Maintains	$120 → $125	+59.52%	Jan 8, 2026
Glen Santangelo Barclays	Barclays	Buy Initiates $118	Buy	Initiates	$118	+50.59%	Dec 9, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

1.33B

from 1.20B

10.44%

from 1.20B

Revenue Next Year

1.42B

from 1.33B

7.47%

from 1.33B

EPS This Year

4.00

from 1.09

266.60%

from 1.09

EPS Next Year

4.59

from 4.00

14.89%

from 4.00

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jan 31, 2021	Jan 31, 2022	Jan 31, 2023	Jan 31, 2024	Jan 31, 2025	Jan 31, 2026	Jan 31, 2027
Revenue	733.57M	756.56M	861.75M	999.59M	1.20B	1.33B	1.42B
Revenue Growth	37.89%	3.13%	13.90%	16.00%	20.03%	10.44%	7.47%
EPS	0.12	-0.53	-0.31	0.64	1.09	4.00	4.59
EPS Growth	-79.48%	-	-	-	70.31%	266.60%	14.89%
Forward PE	-	-	-	-	-	19.61	17.07
No. Analysts	-	-	-	-	-	17	16

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	1.4B	1.5B
Avg	1.3B	1.4B
Low	1.3B	1.4B

Revenue Growth

Revenue Growth	2026	2027
High	15.4%	13.0%
Avg	10.4%	7.5%
Low	6.8%	2.6%

EPS Forecast

EPS	2026	2027
High	4.21	4.98
Avg	4.00	4.59
Low	3.84	4.25

EPS Growth

EPS Growth	2026	2027
High	286.3%	24.5%
Avg	266.6%	14.9%
Low	252.4%	6.4%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.